Recent progress of nano-drug delivery systems in gastrointestinal cancer

Author:

Guan Xiaoqi1,Zhang Ke1,Mei Xianghuang1,He Zhipeng1,Su Shi1,Yang Jingcheng1,Lv Jiake1,Yuan Li2,Duan Xiao3,Guo Wei1

Affiliation:

1. Department of Gastrointestinal Surgery, Heji Hospital Affiliated to Changzhi Medical College, Changzhi Medical College, Changzhi, 046000, China

2. Department of Physiology, Changzhi Medical College, Changzhi, 046000, China

3. Department of Pharmacy, Changzhi Medical College, Changzhi, 046000, China

Abstract

Gastrointestinal cancer is a major cancer type with a high incidence worldwide. In China, most patients with gastrointestinal tumors are diagnosed in the late stage and are unsuitable for surgery. Chemotherapy is the last treatment option for most advanced tumor patients. However, it always leads to severe side effects on the human body. The emergence of nano-carrier-based drug delivery can remarkably increase drug efficiency and avoid severe side effects in cancer patients. This article reviews the therapeutic application of nano-drug delivery systems (NDDSs) in gastrointestinal tumors in recent years, which is expected to improve the quality of life of advanced cancer patients and help develop more nano-drugs for gastrointestinal cancer patients.

Publisher

American Scientific Publishers

Subject

General Materials Science

Reference97 articles.

1. Pembrolizumab for treatment of advanced gastric and gastroesophageal junction adenocarcinoma;Joshi;Future Oncology,2018

2. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: A Cancer Journal for Clinicians,2021

3. Study on early diagnosis of gastcic cancer;Zhou;Chinese Journal of Gastroenterology and Hepatology,2020

4. Engineered nanoparticles for drug delivery in cancer therapy;Sun;Angewandte Chemie (International ed. in English),2014

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA: A Cancer Journal for Clinicians,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3